Revamp Your Sepsis Bundle – Controversies with Vasopressors in Septic Shock
Speaker Heading link
Speakers:
Sean P. Kane, PharmD, BCPS
Associate Professor, Pharmacy Practice and Assistant Dean for Assessment; Rosalind Franklin
University of Medicine and Science, North Chicago, IL
Critical Care Pharmacist; Advocate Condell Medical Center, Libertyville, IL
and
Candice Schaper, MSN, RN, CFRN, CCRN, CEN, PHRN
UCAN Flight Nurse
University of Chicago Medicine
Session Information Heading link
A Knowledge-Based Activity
ACPE UAN # 0016-0000-23-033-L01-P, 1.0 contact hour, 1.0 AMA PRA Category 1 Credit(s)™ CME, 1.0 contact hour CNE
Learning Objectives:
- Explain the concept of a “maximum” dose of a vasopressor for septic shock and identify strategies to achieve goal mean arterial pressure in patients who exceed this maximum.
- Discuss optimal sedation strategies for mechanically ventilated patients with septic shock requiring vasopressor therapy.
- Describe risk associated with use of vasopressors through peripheral access.
- Review risks associated with specific vasopressor agents used peripherally.
- Describe reasonable surveillance of peripheral IV with administration of vasopressor agents and options for management of an identified extravasation event.
Speaker Disclosures
All other speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial relationships with ineligible companies to disclose.
Modified on May 30, 2023